Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multiple-Dose, Randomized, Placebo-Controlled, Study of LY3462817 or LY3509754 in Patients With Psoriasis

NCT04152382 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT04152382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04152382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multiple-Dose, Randomized, Placebo-Controlled, Study of LY3462817 or LY3509754 in Patients With Psoriasis
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Terminated
Start date
November 20, 2019
Completion date
February 9, 2022
Enrollment
30 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis